ArticleInternational journal of molecular sciences2026
Adaptive Self-Attention Graph Pooling for Drug-Target Affinity Prediction.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-target affinity (DTA) prediction is a critical step in drug discovery and precision medicine. Although graph neural networks (GNNs) have achieved remarkable progress, existing graph pooling methods rely on fixed ratios, failing to adapt to the structural diversity of molecules and proteins, which leads to information loss or redundant feature retention. To address this issue, we propose the Adaptive Self-Attention Graph Pooling (ASAGPooling) mechanism, which introduces a learnable pooling ratio that dynamically adjusts node retention during training. Furthermore, we develop ASAG-DTA, a multi-modal framework that integrates GNNs with Transformers to jointly model molecular graphs, protein contact maps, SMILES sequences, and FASTA sequences. While ASAGPooling achieves competitive prediction accuracy (MSE = 0.186 on Davis), we acknowledge that it does not surpass the state-of-the-art DynHeter-DTA (MSE = 0.130), which incorporates a more complex dynamic heterogeneous graph architecture. Instead, the key contribution of ASAGPooling lies in its adaptability, interpretability, and computational efficiency. It can eliminate the need for manually tuned pooling ratios, enable direct visualization of retained key residues/atoms, and reduce model complexity. This makes ASAG-DTA a practical lightweight alternative for large-scale virtual screening scenarios where computational resources are constrained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.